Merck & Co., Inc. (MRK) Stock Price Today
Aura AI Summary
Key Stats
- $357.02BMarket Cap
- -Volume
- HealthSector
- $156.4352W High
- $77.6052W Low
- -Typical Hold Time
- $403.79BEnterprise Value
- 2.35%Div Yield
- -Trading Activity
Track Merck & Co., Inc. (MRK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Merck & Co., Inc. has traded between a low of $77.6 and a high of $156.43, highlighting its annual price range. Buy and sell Merck & Co., Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Most Recent News
New rate hike boosts American Water's revenue by $68M, fueling $1.4B infrastructure upgrades and analyst optimism.
New Jersey American Water received approval for rate increases that will add $68 million annually to its revenue. This funding supports over $1.4 billion in critical infrastructure upgrades, including replacing aging water mains and improving treatme...
Nike shares drop 40% YTD amid broad athletic apparel selloff, raising questions on recovery or continued slump.
Nike stock has fallen 40% this year, mirroring declines in peers On Holding and Lululemon, which are down 41% and 53% respectively. This suggests the drop is due to a broad category selloff in athletic apparel rather than company-specific issues. Des...
AI safety concerns rise as experts quit; cybersecurity firms poised to benefit from AI threat surge
Key AI researchers are quitting over fears that the AI industry is rushing to develop uncontrollable superintelligence. Despite these safety concerns and repeated incidents of AI systems losing control, the pace of AI development is expected to conti...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.